Vitrolife AB | Cash Flow

Fiscal year is January-December. All values SEK Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
79,788.00
146,924.00
226,840.00
248,930.00
340,915.00
398,583
Depreciation, Depletion & Amortization
34,912.00
23,250.00
45,507.00
54,044.00
66,470.00
84,692
Other Funds
-
-
262.00
855.00
284.00
99,099
Funds from Operations
105,107.00
140,380.00
214,363.00
220,656.00
322,278.00
384,176
Changes in Working Capital
1,020.00
5,286.00
20,837.00
39,394.00
10,089.00
34,741
Net Operating Cash Flow
106,127.00
145,666.00
193,526.00
181,262.00
312,189.00
349,435
Capital Expenditures
8,491.00
8,920.00
22,629.00
13,752.00
10,473.00
Sale of Fixed Assets & Businesses
19.00
-
-
-
294.00
Purchase/Sale of Investments
4,016.00
790.00
371.00
748.00
199.00
Net Investing Cash Flow
14,387.00
77,517.00
31,394.00
131,002.00
9,980.00
Cash Dividends Paid - Total
11,899.00
20,239.00
32,565.00
52,104.00
56,447.00
Issuance/Reduction of Debt, Net
37,306.00
535.00
36,621.00
12,347.00
37,333.00
Net Financing Cash Flow
49,205.00
19,704.00
68,924.00
63,596.00
93,496.00
Net Change in Cash
42,089.00
53,829.00
91,974.00
10,327.00
206,718.00
Free Cash Flow
99,468.00
139,643.00
183,987.00
171,293.00
302,687.00
Net Assets from Acquisitions
1,899.00
67,807.00
9,136.00
116,502.00
-
Exchange Rate Effect
446.00
5,384.00
1,234.00
3,009.00
1,995.00

About Vitrolife AB

View Profile
Address
Gustaf Werners Gata 2
Gothenburg VG 421 32
Sweden
Employees -
Website http://www.vitrolife.com
Updated 07/08/2019
Vitrolife AB engages in the development, manufacture, and sale of products and systems for the preparation, cultivation, and storage of human cells, tissue, and organs. It operates through the following geographical segments: EMEA, North and South America, and Asia & Pacific. Its products include FertiRoof, Vitrification, Slow freezing, OVOIL-culture oil, and Follicle aspiration needles.